Menlo to continue healthcare push at intersection of tech, life sciences with $500M fund

Greg Yap joined Menlo Ventures three years ago to ramp up the firm’s healthcare focus after a 20-year hiatus. Menlo apparently liked what it saw as Yap and his colleagues have $500 million to deploy from a new early-stage fund that will go in part to digital health companies, data-heavy biotechs and platform therapeutics plays.

“We’ve been able to re-establish healthcare and life sciences as a core focus for the firm,” Yap told BioCentury. ...